BioCentury
ARTICLE | Company News

Infinity management update

February 10, 2014 8:00 AM UTC

Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Cambridge, Mass. Business: Cancer, Inflammation Promoted: David Roth to CMO from SVP of clinical development and medical affairs; he succeeds Pedro Santaba...